Health and Family Welfare Ministry’s notification on ‘hydroxychloroquine’

Updated - March 28, 2020 01:47 pm IST

Published - March 28, 2020 01:13 pm IST

File photo of Nivaquine, tablets containing chloroquine, a commonly used malaria drug that has shown signs of effectiveness against coronavirus.

File photo of Nivaquine, tablets containing chloroquine, a commonly used malaria drug that has shown signs of effectiveness against coronavirus.

Hydroxychloroquine  is now a schedule H1 drug, and can be sold on prescription only.

According to a gazette notification issued by the Union Health Ministry, the sale of the drug from now on should be in accordance with the conditions for sale of drugs specified in Schedule H1 to the Drugs and Cosmetics Rules, 1945. Here is the official notification:

 

Health and Family Welfare Ministry’s notification on ‘hydroxychloroquine’

0 / 0
Sign in to unlock member-only benefits!
  • Access 10 free stories every month
  • Save stories to read later
  • Access to comment on every story
  • Sign-up/manage your newsletter subscriptions with a single click
  • Get notified by email for early access to discounts & offers on our products
Sign in

Comments

Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.

We have migrated to a new commenting platform. If you are already a registered user of The Hindu and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.